Sort
25,944 grants matching “neurodegeneration”
Large-Scale Genomic Analysis of Aging-Related Cognitive Change Prior to Dementia Onset
$622,383Elliot Max Tucker-Drob · University Of Texas At Austin · R01 · FY2025 · AG
Temporal and spatial aspects of amyloidogenesis in sporadic Alzheimer disease
$622,244Malcolm A Leissring · University Of California-Irvine · R01 · FY2024 · AG
CHEMOKINES AND CHEMOKINE RECEPTORS IN SIV ENCEPHALITIS
$622,178Johns Hopkins University · R01 · FY2000 · MH
Neuronal FXR as a potential therapeutic target for Alzheimer's disease
$622,119Julie Kay Andersen · Buck Institute For Research On Aging · R01 · FY2021 · AG
Gene expression in the human brain
$622,095Mark Cookson · National Institute On Aging · ZIA · FY2019 · AG
Unraveling microglial NOD2/RIPK2 signaling: Implications for neuroinflammation and neurodegeneration in Alzheimer's disease
$622,086Hanseok Ko · Johns Hopkins University · R01 · FY2025 · AG
Understanding the role of patient-derived Ighmbp2 mutations in neurodegeneration and pre-rRNA processing
$622,078Christian L. Lorson · University Of Missouri-Columbia · R01 · FY2024 · NS
Training in the Molecular Biology of Neurodegeneration
$622,075Bruce A Yankner · Harvard Medical School · T32 · FY2006 · AG
Characterizing and modulating neurocognitive processes of learning to trust and distrust in aging
$622,022Natalie C Ebner · University Of Florida · R01 · FY2025 · AG
Modulation of Hippocampal Circuitry and Memory Function with Focused Ultrasound in Amnestic MCI
$621,961Susan Y Bookheimer · University Of California Los Angeles · R01 · FY2021 · AG
Non-Invasive Imaging Markers to Elicit the Role of Vascular Involvement in Alzheimerâs Disease
$621,935Kevin Michael Johnson · University Of Wisconsin-Madison · R01 · FY2025 · AG
Towards Therapeutics for Neurodegenerative Diseases
$621,851Stanley B Prusiner · University Of California, San Francisco · R37 · FY2014 · AG
Trajectories and Markers of Neurodegeneration in Fragile X Premutation Carriers
$621,805Susan M Rivera · University Of California At Davis · R01 · FY2020 · NS
T cell immunity in a rare juvenile form of motor neuron disease
$621,769Ivan Marazzi · University Of California-Irvine · R01 · FY2024 · NS
Imaging of glutamatergic system changes in Alzheimer's disease in vivo
$621,697Ravinder Reddy · University Of Pennsylvania · R01 · FY2024 · AG
Imaging of glutamatergic system changes in Alzheimer's disease in vivo
$621,697Ravinder Reddy · University Of Pennsylvania · R01 · FY2023 · AG
Signal Transduction to P70 S6 Kinase 1
$621,611John Blenis · Weill Medical Coll Of Cornell Univ · R01 · FY2015 · GM
Infection-driven mechanisms associated with Alzheimer's disease pathology
$621,580Rodrigo Morales · University Of Texas Hlth Sci Ctr Houston · R01 · FY2024 · AG
Development of P2Y Receptor Ligands
$621,513Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
Re-visiting Methods for MCI Diagnosis to Improve Biomarker and Trial Findings
$621,407Mark W Bondi · University Of California, San Diego · R01 · FY2020 · AG
Stress Granules and the Biology of TDP-43
$621,092Benjamin L Wolozin · Boston University Medical Campus · R01 · FY2012 · ES
Cerebrospinal fluid dynamics in Huntington's disease
$621,073Daniel Oliver Claassen · Vanderbilt University Medical Center · R01 · FY2025 · NS
Neuronal FXR as a potential therapeutic target for Alzheimer's disease
$621,072Julie Kay Andersen · Buck Institute For Research On Aging · R01 · FY2020 · AG
Molecular Basis of Pathogenic Cascades in ALS/FTD Initiated from C9orf72 Hexanucleotide Repeat Expansion
$621,007Jiou Wang · Johns Hopkins University · R01 · FY2023 · NS
Project 4: Consequences of Retrotransposable Element Activation in the Central Nervous System
$620,892Fred H Gage · Brown University · P01 · FY2022 · AG